Advances in Cardiomyopathies [electronic resource] /

Introduction: Thirty Years of Cardiomyopathy -- I Hypertrophic Cardiomyopathy -- Evolution of Left Ventricular Hypertrophy in Patients with Hypertrophic Cardiomyopathy -- The Natural History and Clinical Course of Hypertrophic Cardiomyopathy -- Left Ventricular Systolic and Diastolic Function in Hypertrophic Cardiomyopathy -- Radionuclide Assessment of Diastolic Function in Hypertrophic Cardiomyopathy: Relation to Symptoms and Prognosis -- Ischemia, Coronary Blood Flow, and Coronary Reserve in Hypertrophic Cardiomyopathy -- Left Ventricular Diastolic Function and Myocardial Ischemia in Hypertrophic Cardiomyopathy: Assessment by Radionuclide Methods -- Sudden Death in Hypertrophic Cardiomyopathy: Identification and Management of High Risk Patients -- Electrophysiologic Studies in Patients with Hypertrophic Cardiomyopathy: Safety and Relation of Results to Clinical Findings -- Cerebral Embolic Risk in Hypertrophic Cardiomyopathy -- Cytogenetic Studies in Familial Hypertrophic Cardiomyopathy: Identification of a Fragile Site on Human Chromosome 16 -- Medical Treatment of Hypertrophic Cardiomyopathy -- Surgical Results in Patients with Hypertrophic Obstructive Cardiomyopathy -- Utility of Intraoperative Echocardiography in Planning Surgical Strategy in Obstructive Hypertrophic Cardiomyopathy -- Rational Choice of Medical and/or Surgical Therapy in Hypertrophic Cardiomyopathy -- Changes in Left Ventricular Hemodynamics of Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients Treated with VAT Sequential Pacing -- Future Trends in Research in Hypertrophic Cardiomyopathy -- II Dilated Cardiomyopathy -- 1 Pathogenesis of Dilated Cardiomyopathy -- Experimental Viral Myocarditis: Immunopathogenetic Aspects -- Dichotomous Effects of Cyclophosphamide in Murine Coxsackievirus B3-Induced Myocarditis -- Enterovirus RNA Sequences in Hearts with Dilated Cardiomyopathy: A Pathogenetic Link Between Virus Infection and Dilated Cardiomyopathy -- HLA Haplotype in Idiopathic Dilated Cardiomyopathy: Genetically Determined Immune Response Factors of Etiologic Importance? -- Humoral and Cell-Mediated Immunity: Pathogenetic Mechanisms in Dilated Cardiomyopathy -- Biomolecular Changes in Dilated Cardiomyopathy -- The ?-Adrenergic Receptor-G Protein-Adenylate Cyclase Complex in Idiopathic Dilated Cardiomyopathy -- Immune-Genetic Control of Anti-?-Receptor Antibodies in Human Idiopathic Dilated Cardiomyopathy -- Catecholamines, ?-Receptors and Morphology in Dilated Cardiomyopathy: A Preliminary Report -- 2 Morphology of Dilated Cardiomyopathy -- Histopathological Diagnosis of Acute Myocarditis and Dilated Cardiomyopathy -- Ultrastructural Changes in Myocarditis and Dilated Cardiomyopathy -- Diagnostic and Prognostic Value of Immunofluorescence and Electron-Microscopic Findings in Idiopathic Dilated Cardiomyopathy -- 3 Clinical Aspects and Treatment of Myocarditis -- Natural History of Viral Myocarditis: Critical Viewpoints -- Clinical Presentation and Evolution in Treated and Untreated Myocarditis -- Immunosuppressive Therapy in Active Myocarditis -- Immunosuppressive Therapy in Myocarditis — 24-Month Follow-up -- 4 Clinical Aspects of Dilated Cardiomyopathy -- Natural History and Prognosis of Overt Dilated Cardiomyopathy -- Myocardial Perfusion and Metabolism in Dilated Cardiomyopathy -- Complex Ventricular Arrhythmias in Dilated Cardiomyopathy: A Multicenter Italian Experience -- Essential Ventricular Arrhythmias: An Early Step Toward Cardiomyopathy? -- Role of Radionuclide Angiography in the Diagnosis of Early Ventricular Dysfunction in Patients with Complex Ventricular Arrhythmias -- Italian Multicenter Cardiomyopathy Study Group -- Dilated Cardiomyopathy in Children -- Anatomoclinical Aspects of Arrhythmogenic Right Ventricular Cardiomyopathy -- Right Ventricular Arrhythmogenic Cardiomyopathy: The Clinical Point of View -- Arrhythmologic Study in Arrhythmogenic Right Ventricular Dysplasia: Prognostic Implications in Fifty Patients -- 5 Treatment of Dilated Cardiomyopathy -- Positive Inotropic Therapy for Chronic Dilated Cardiomyopathy and Congestive Failure -- Vasodilator Therapy for Cardiomyopathy -- Beta-Blockade in Dilated Cardiomyopathy -- Role of Antiarrhythmic Treatment in Dilated Cardiomyopathy -- Cardiac Transplantation for Dilated Cardiomyopathy -- Long-Term Treatment with Amiodarone for the Prevention of Sudden Death in Patients with Dilated Cardiomyopathy.